180 related articles for article (PubMed ID: 11266816)
21. Role of CTLA 4-Ig on induction of unresponsiveness to multiple minor alloantigens.
Gorczynski RM; Kiziroglu F
Transpl Int; 1994; 7 Suppl 1():S599-601. PubMed ID: 11271318
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
[TBL] [Abstract][Full Text] [Related]
23. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
[TBL] [Abstract][Full Text] [Related]
24. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
[TBL] [Abstract][Full Text] [Related]
25. Failure of combined costimulatory blockade in animal transplant model.
Dharnidharka VR; Schowengerdt K; Skoda-Smith S
Nat Med; 2000 Feb; 6(2):115. PubMed ID: 10655074
[No Abstract] [Full Text] [Related]
26. Inhibition of corneal allograft reaction by CTLA4-Ig.
Hoffmann F; Zhang EP; Pohl T; Kunzendorf U; Wachtlin J; Bulfone-Paus S
Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
[TBL] [Abstract][Full Text] [Related]
27. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
Tang JL; Woodward JE; Subbotin V; Logar AJ; Sun H; Valdivia LA; Schaefer AT; Zottola LB; Peach R; Fung JJ; Rao AS
Transplant Proc; 2001; 33(1-2):382. PubMed ID: 11266872
[No Abstract] [Full Text] [Related]
28. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
30. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
Rastellini C; Salam A; Kuddus R; Aitouche A; Subbotin V; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1242-3. PubMed ID: 10083554
[No Abstract] [Full Text] [Related]
31. Importance of the CD28/B7 costimulatory pathway in the development of chronic ductopenic rejection in a new model of orthotopic rat liver allotransplantation.
Mark W; Hechenleitner P; Sayegh MH; Hancock WW; Candinas D
Transplant Proc; 1997; 29(1-2):1029. PubMed ID: 9123182
[No Abstract] [Full Text] [Related]
32. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
33. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice.
Yin D; Ma L; Shen J; Byrne GW; Logan JS; Chong AS
Am J Transplant; 2002 Jan; 2(1):41-7. PubMed ID: 12095055
[TBL] [Abstract][Full Text] [Related]
34. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS
Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428
[TBL] [Abstract][Full Text] [Related]
35. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
[TBL] [Abstract][Full Text] [Related]
36. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
37. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
Fu F; Li W; Lu L; Fung JJ; Thomson AW; Qian S
Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185
[No Abstract] [Full Text] [Related]
38. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
[No Abstract] [Full Text] [Related]
40. CD40-ligand in primate cardiac allograft and viral immunity.
Pierson RN; Crowe JE; Pfeiffer S; Atkinson J; Azimzadeh A; Miller GG
Immunol Res; 2001; 23(2-3):253-62. PubMed ID: 11444390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
